May 08, 2025

FDA Warns Physicians of Tianeptine Dangers

The FDA warns physicians about unapproved tianeptine products that are linked to severe adverse events, including dependence, toxicity, and death.

Conexiant

May 08, 2025

Early Menopause Linked to Long-Term Cognitive Decline, Study

A large UK-based cohort study found that early menopause—before age 40—is associated with both higher depressive symptoms and worse cognitive function over time.

Conexiant

May 05, 2025

Men With Panic Disorder Use More Substances, Study 

Researchers analyzed over 10,000 adults and found that individuals with panic disorder reported more severe alcohol and tobacco use, especially among men, with no significant differences across racial groups.

Conexiant

May 02, 2025

Psychotherapy, Family Tied to Better Outcomes

In a large meta-analysis, researchers identified the most effective components of collaborative care for treating depression in primary care.

Conexiant

May 01, 2025

FDA Approves Intranasal DHE for Acute Migraine Relief

The FDA has approved Atzumi for the acute treatment of migraine with or without aura in adults.

Conexiant

April 28, 2025

Esketamine Plus SNRI Cuts Relapse, Study

Real-world study finds esketamine combined with an SNRI linked to lower mortality, hospitalization, and relapse rates compared to esketamine plus SSRI in treatment-resistant depression.

Conexiant

April 25, 2025

Global Study Maps Loneliness Across Age Groups

Loneliness doesn't always increase with age.

Conexiant

April 25, 2025

Opioid Use High in Adults With Cerebral Palsy 

Over 50% exhibited a mixed pain phenotype, researchers wrote, linking cerebral palsy pain types to increased opioid use and treatment complexity.

Conexiant

April 24, 2025

FDA Warns of Topical Finasteride Risks

The FDA has issued a safety alert on compounded topical finasteride products, citing adverse events and emphasizing the lack of regulatory approval or safety evaluation.

Conexiant